ST. ALPHONSUS REGIONAL MED CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.7M
- Transactions
- 671
- Companies
- 40
- Average per transaction
- $3,953
Who reported the payments
| Merck | $600,846 |
| Edwards Lifesciences | $498,145 |
| Amgen | $286,958 |
| Cvrx, Inc. | $159,974 |
| Stryker | $131,245 |
| Bristol Myers Squibb | $111,163 |
| Arthrex | $108,640 |
| Atricure, Inc. | $101,768 |
| Incyte Corporation | $70,231 |
| E.r. Squibb & Sons, L.L.C. | $62,314 |
| Helios Cardio Inc | $50,000 |
| Abbott | $38,007 |
| Boston Scientific | $34,623 |
| Biotronik Inc. | $33,785 |
| Genentech, Inc. | $29,849 |
| Livanova USA, Inc. | $29,010 |
| Genentech USA, Inc. | $27,500 |
| Janssen Research & Development, LLC | $27,452 |
| Acutus Medical, Inc. | $26,996 |
| Shockwave Medical, Inc | $22,180 |
| Medtronic | $22,065 |
| Cepheid | $20,500 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18,735 |
| G1 Therapeutics, Inc. | $15,651 |
| Eli Lilly | $14,013 |
| AbbVie | $13,844 |
| Tandem Diabetes Care, Inc. | $13,300 |
| GT Medical Technologies, Inc | $10,978 |
| Bio-rad Laboratories, Inc. | $9,016 |
| Insulet Corporation | $8,625 |
| Medartis Inc. | $7,974 |
| Spectrum Pharmaceuticals Inc. | $7,545 |
| Novartis | $7,339 |
| Boehringer Ingelheim | $4,653 |
| AstraZeneca | $4,635 |
| Helsinn Healthcare SA | $4,100 |
| Teleflex LLC | $2,215 |
| Helena Laboratories Corporation | $2,026 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $2,000 |
| ZOLL Medical Corporation | $1,400 |